Riskpilot← Back to searchSign inGet full accessEPS Vascular AB
ABActiveOrg 5567803183Hamnplanen 24Wholesale of pharmaceutical and medical goods · NACE 4646Est. 200914 employees
Revenue 2024
SEK 192,4M
+7% vs 2023
EBITDA margin
7.1%
+1% vs 2023
Equity ratio
21.7%
Financial strength
Net profit 2024
SEK 9,9M
+3% vs 2023
| Revenue | SEK 192,4M | +7% |
| EBITDA | SEK 13,7M | +1% |
| Net profit | SEK 9,9M | +3% |
| Total assets | SEK 77,3M | +10% |
| Equity | SEK 16,7M | -20% |
| Employees | 14 | — |
Legal name
EPS Vascular AB
Org number
5567803183
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1 april 2009
Share capital
SEK 100 000
Employees
14 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Firman tecknas ensam av externa firmatecknaren Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska bedriva distribution och tillverkning av medicinsktekniska produkter jämte därmed förenlig verksamhet.
Address
Hamnplanen 24
Phone
+46766336510
Email
info@epsvascular.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 126 061 | 144 388 | 165 371 | 180 307 | 192 374 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 22 130 | 19 269 | 19 658 | 13 551 | 13 712 |
| Depreciation & amort. | −0 | −13 | −60 | −69 | −57 |
| EBIT | 22 130 | 19 256 | 19 598 | 13 482 | 13 655 |
| Net financials | −10 | 28 | −10 | 182 | 150 |
| Profit before tax | 17 920 | 16 283 | 17 289 | 12 564 | 13 190 |
| Tax | −4 053 | −3 557 | −3 837 | −2 974 | −3 270 |
| Net profit | 13 867 | 12 726 | 13 452 | 9 590 | 9 920 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 61 136 | 72 180 | 64 462 | 70 272 | 77 258 |
| Equity | 19 650 | 17 376 | 18 828 | 20 819 | 16 738 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 18 600 | 28 918 | 17 448 | 20 167 | 30 620 |
| Total debt | 18 600 | 28 918 | 17 448 | 20 167 | 30 620 |
EBITDA margin
7.1%
This company
15.8%
Market median
-55% vs market
20202024
Equity ratio
21.7%
This company
38.2%
Market median
-43% vs market
20202024
Return on equity
59.3%
This company
18.4%
Market median
+222% vs market
20202024
Net profit margin
5.2%
This company
8.1%
Market median
-36% vs market
20202024
Asset turnover
2.49×
This company
1.12×
Market median
+122% vs market
20202024
Debt / equity
3.62×
This company
0.62×
Market median
-484% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
SJ Chief Executive Officer | Chief Executive Officer | 2022 |
CT Audit | Audit | 2021 |
SO External Signatory | External Signatory | 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2021 | |
| Board of Directors | 2022 | |
| Former (2) | ||
| Board of Directors | 2021 – 2023 | |
| Board of Directors | 2021 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
UNIPHAR EUROPE LTD
EPS Vascular AB (this company)Board members of EPS Vascular AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Set Joakim Eriksson | Chief Executive Officer | 0 companies |
| Carl Teddie Leidhem | Audit | 0 companies |
| Seth Ola Patrick Mårtensson | External Signatory | 0 companies |
| Curt-Jörgen Per Petersson | Board of Directors | 0 companies |
| Padraic William Dempsey | Board of Directors | 0 companies |
| Timothy Dolphin | Chairman | 0 companies |
| Siobhan Brigid Taaffe | Board of Directors | 0 companies |